Recombinant Human CCL2/MCP-1
CCL2, also called monocyte chemotactic protein-1 (MCP-1) or JE, is a member of the C-C or beta chemokine family that is best known as a chemotactic agent for mononuclear cells [1, 2]. Human CCL2 cDNA encodes a 99 amino acid (aa) precursor protein with a 23 aa signal peptide and a 76 aa mature protein [2]. Removal of the first 5 aa of the mature protein, including the N-terminal pyrrolidone carboxylic acid-modified glutamine, occurs naturally by metalloproteinase cleavage and down-regulates activity but not receptor binding [3]. CCL2 may form multiple bands from 8.7-13.5 kDa on SDS-PAGE due to non-covalent dimerization and variable carbohydrate content[3]. Mature human CCL2 shares 78-79% aa identity with canine, porcine and equine CCL2, while mouse and rat express a form of CCL2 that is extended by 49 aa and shares only ~56% aa identity within the common region. Human CCL2 can, however, induce a response in murine cells [4]. Fibroblasts, glioma cells, smooth muscle cells, endothelial cells, lymphocytes and mononuclear phagocytes can produce CCL2 either constitutively or upon mitogenic stimulation, but monocytes and macrophages appear to be the major source [1, 2]. In addition to its chemotactic activity, CCL2 induces enzyme and cytokine release by monocytes, NK cells and lymphocytes, and histamine release bybasophils that express its receptor, CCR2 [2]. Additionally, it promotes Th2 polarization in CD4+ T cells [5]. CCL2-mediated recruitment of monocytes to sites of inflammation is proposed to play a role in the pathology of atherosclerosis, multiple sclerosis and allergic asthma [6, 7].
Reference
[1]. Yoshimura, T. et al. (1989) FEBS Lett. 244:487.
[2]. Deshmane, S.L. et al. (2009) J. Interferon Cytokine Res. 29:313.
[3]. Proost, P. et al.(1998) J. Immunol. 160:4034.
[4]. Ju Lee, H. et al. (2015) J. Immunol. 194:3634.
[5]. Luther, S.A. and J.G. Cyster (2001) Nat. Immunol. 2:102.
[6]. Daly, C. et al. (2003) Microcirculation 10:247.
[7]. Aukrust, P. et al. (2008) Arterioscler. Thromb. Vasc. Biol. 28:1909
Accession # |
P13500 |
Alternate Names |
CCL2; GDCF-2; HC11; HSMCR30; MCAF; Mcp1; MCP-1; SCYA2; SMC-CF |
Source |
Human embryonic kidney cell, HEK293-derived human CCL2/MCP-1 protein |
Protein sequence |
Gln24-Thr99 |
M.Wt |
8.7 kDa |
Appearance |
Solution protein |
Stability & Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70°C as supplied. |
Concentration |
0. 2 mg/mL |
Formulation |
Dissolved in sterile PBS buffer. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers. |
Biological Activity |
The EC50 for this effect is 0.1-1 ng/mL. Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CCR2A. . |
Shipping Condition |
Shipping with dry ice. |
Handling |
Centrifuge the vial prior to opening. |
Usage |
For Research Use Only! Not to be used in humans. |
Quality Control & DataSheet
- View current batch:
-
Purity > 95%, determined by SDS-PAGE.
- Datasheet
Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.